A novel variant of DNM1L expanding the clinical phenotypic spectrum: a case report and literature review.

"Declarations Ethics approval and consent to participateThis study was carried out in accordance with the principles of the Declaration of Helsinki and in a manner consistent with good clinical practice. The study was approved by the Ethics Committee of the Children’s Hospital Affiliated to Zhengzhou University. Signed informed consent was obtained from the patient’s parents. Consent for publicationWritten informed consent for the publication of clinical details was obtained from both parents of the participant. Competing interestsThe authors declare no competing interests. Competing interests The authors declare no competing interests."

"Funding This research was funded by the National Natural Science Foundation of China (82000850). The funding bodies played no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript."